Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
US Army
Merck
Fuji
QuintilesIMS
Dow
UBS
Baxter

Generated: April 26, 2018

DrugPatentWatch Database Preview

SARISOL NO. 1 Drug Profile

« Back to Dashboard

When do Sarisol No. 1 patents expire, and what generic alternatives are available?

Sarisol No. 1 is a drug marketed by Halsey and is included in one NDA.

The generic ingredient in SARISOL NO. 1 is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.
Drug patent expirations by year for SARISOL NO. 1
Synonyms for SARISOL NO. 1
143-81-7
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt
5-Ethyl-5-(1-methylpropyl)barbituric acid sodium salt
5-sec-Butyl-5-ethylbarbituric acid sodium salt
AC1Q1VYO
Asturidon
Barbitab
Barbituric acid, 5-sec-butyl-5-ethyl-, sodium salt
Bubartal
Bubartal TT
Butabarb (TN)
BUTABARBITAL SODIUM
Butabarbital sodium (USP)
Butabarbital sodium [USAN]
Butabarbital sodium [USP]
Butabarbitone sodium
Butabarpal sodium
Butak
Butalan
Butasaron
Butased
Butatal sodium
Butazem
Butibel
Butisol sodium
C10H15N2NaO3
Cambrised
Carrbutabarb
CHEBI:3229
Ciprial
D00699
EINECS 205-611-8
Expansatol
Insolat
Intasedol
Loubarb
LS-23946
Mebutal
Neravan
Noctinal
NSC 11778
Paxital (VAN)
Prelital
Quiebar
Sarisol
SARISOL NO. 2
SCHEMBL122121
Secbubarbital sodium
Secbutabarbital sodique
Secbutabarbital sodium
Secbutabarbital sodium (INN)
Secbutobarbitone sodium
Seda-Bute
Sodium 5-(sec-butyl)-5-ethylbarbiturate
Sodium 5-ethyl-5-(1-methylpropyl)barbiturate
Sodium 5-ethyl-5-sec-butylbarbiturate
Sodium 5-sec-butyl-5-ethylbarbiturate
Sodium butabarbital
Sodium butobarbitone

US Patents and Regulatory Information for SARISOL NO. 1

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halsey SARISOL NO. 1 butabarbital sodium TABLET;ORAL 084719-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Citi
Cantor Fitzgerald
Moodys
Cipla
AstraZeneca
Daiichi Sankyo
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.